Clinical Trial Update: An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B [EARLY_Phase 1]

View source ↗

Summary

An exploratory early-phase clinical study is evaluating EPI-003 Injection for chronic hepatitis B, with the trial status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• EPI-003 Injection (EPI-003)

Snippet

Sponsor: Epigenic Therapeutics, Inc | Conditions: Chronic Hepatitis B | EARLY_Phase 1 | Status: NOT_YET_RECRUITING